Validation of the INNO-LiPA HBV DR Assay (Version 2) in Monitoring Hepatitis B Virus-Infected Patients Receiving Nucleoside Analog Treatment

Hepatitis B virus (HBV) antiviral drug resistance mutations prevent successful outcome of treatment and lead to worsening of liver disease. Detection of its emergence permits opportune treatment with alternative drugs. Unfortunately, the use of newly approved antivirals, including adefovir dipivoxil...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Niesters, H. G. M., Zoulim, F., Pichoud, C., Buti, M., Shapiro, F., D'Heuvaert, N., Celis, L., Doutreloigne, J., Sablon, E.
Формат: Artigo
Язык:Inglês
Опубликовано: American Society for Microbiology (ASM) 2010
Предметы:
Antiviral Agents
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC2826013/
https://ncbi.nlm.nih.gov/pubmed/20065049
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00970-09
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы